Danggui buxue tang inhibits 2,4-dinitrochlorobenzene: Induced atopic dermatitis in mice

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Fang, Li Wen ^a   Cheng, Chao Chun ^b,c   Hwang, Tzann Shun ^d   Huang, Wen Chung ^b   Liou, Chian Jiun ^b   Chen, Wen Chyuan ^b   Wu, Shu Ju ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ANTIINFLAMMATORY AGENT; CHINESE DRUG; DANGGUI BUXUE TANG; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; EOSINOPHIL; FEMALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN SWELLING; SPLEEN CELL; TH2 CELL; TREATMENT DURATION;

EID: 84925600397     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/672891     Document Type: Article

References (35)

1. T. Bieber, M. Cork, and S. Reitamo, "Atopic dermatitis: a candidate for disease-modifying strategy," Allergy, vol. 67, no. 8, pp. 969-975, 2012.
2. M. S. de Bruin Weller, A. C. Knulst, Y. Meijer, C. A. F. M. Bruijnzeel-Koomen, and S. G. M. Pasmans, "Evaluation of the childwith atopic dermatitis," Clinical and Experimental Allergy, vol. 42, no. 3, pp. 352-362, 2012.
3. Y. Tokura, "Extrinsic and intrinsic types of atopic dermatitis," Journal of Dermatological Science, vol. 58, no. 1, pp. 1-7, 2010.
4. R. Berke, A. Singh, and M. Guralnick, "Atopic dermatitis: an overview," American Family Physician, vol. 86, no. 1, pp. 35-42, 2012.
5. M. Boguniewicz and D. Y. M. Leung, "Atopic dermatitis: a disease of altered skin barrier and immune dysregulation," Immunological Reviews, vol. 242, no. 1, pp. 233-246, 2011.
6. S. Guglielmetti, J.K. Dart, and V. Calder, "Atopickeratoconjunctivitis and atopic dermatitis," Current Opinion in Allergy and Clinical Immunology, vol. 10, no. 5, pp. 478-485, 2010.
7. A. U. Tan and M. E. Gomzalez, "Management of severe atopic dermatitis in children," Journal of Drugs in Dermatology, vol. 11, no. 10, pp. 1158-1165, 2012.
8. M. J. Turner, J. B. Travers, and M. H. Kaplan, "T helper cell subsets in the development of atopic dermatitis," Journal of Drugs in Dermatology, vol. 11, no. 10, pp. 1174-1178, 2012.
9. E. B. Brandt and U. Sivaprasad, "Th2 cytokines and atopic dermatitis," Journal of Clinical & Cellular Immunology, vol. 2, no. 3, article 110, 2011.
10. K. Eyerich and N. Novak, "Immunology of atopic eczema: overcoming the Th1/Th2 paradigm," Allergy, vol. 68, no. 8, pp. 974-982, 2013.
11. C.-C. Lin, C.-J. Liou, C.-Y. Chiang, W.-Y. Huang, and W.-C. Huang, "Danggui Buxue Tang attenuates eosinophil infiltration and airway hyperresponsiveness in asthmatic mice," Annals of Allergy, Asthma&Immunology, vol. 107, no. 6, pp. 501-509, 2011.
12. W. L. Zhang, K. Y. Z. Zheng, K. Y. Zhu et al., "Chemical and biological assessment of Angelica roots from different cultivated regions in a Chinese herbal decoction Danggui Buxue Tang," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 483286, 10 pages, 2013.
13. J. Gao, Y. Huang, P. Li et al., "Antifibrosis effects of total glucosides ofDanggui-Buxue-Tang in a ratmodel of bleomycininduced pulmonary fibrosis," Journal of Ethnopharmacology, vol. 136, no. 1, pp. 21-26, 2011.
14. J. Lv, Z. Zhao, Y. Chen et al., "The Chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 284963, 11 pages, 2012.
15. Y. Chen, Q. Chen, J. Lu, F. H. Li, Y. Y. Tao, and C. H. Liu, "Effects of Danggui Buxue decoction on lipid peroxidation and MMP-2/9 activities of fibrotic liver in rats," Chinese Journal of Integrative Medicine, vol. 15, no. 6, pp. 435-441, 2009.
16. C.C. Wang, K. F. Cheng, W.M. Loet al., "Arandomized, doubleblind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women," Menopause, vol. 20, no. 2, pp. 223-231, 2013.
17. C.-C. Chan, C.-J. Liou, P.-Y. Xu et al., "Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse," Journal of Dermatological Science, vol. 72, no. 2, pp. 149-157, 2013.
18. W.-C. Huang, M.-L. Kuo, M.-L. Li, R.-C. Yang, C.-J. Liou, and J.- J. Shen, "Gynostemma pentaphyllum decreases allergic reactions in a murine asthmatic model," The American Journal of Chinese Medicine, vol. 36, no. 3, pp. 579-592, 2008.
19. K. B. Yarbrough, K. J. Neuhaus, and E. L. Simpson, "The effects of treatment on itch inatopicdermatitis," DermatologicTherapy, vol. 26, no. 2, pp. 110-119, 2013.
20. A. Torrelo, J. Ortiz, A. Alomar, S. Ros, M. Prieto, and J. Cuervo, "Atopic dermatitis: impact on quality of life and patients' attitudes toward its management," European Journal of Dermatology, vol. 22, no. 1, pp. 97-105, 2012.
21. M. S. de Bruin Weller, H. Rockmann, A. C. Knulst, and C. A. F. M. Bruijnzeel-Koomen, "Evaluation of the adult patient with atopic dermatitis," Clinical and Experimental Allergy, vol. 43, no. 3, pp. 279-291, 2013.
22. E. L. Simpson, "Atopic dermatitis: a review of topical treatment options," Current Medical Research and Opinion, vol. 26, no. 3, pp. 633-640, 2010.
23. M. Niebuhr, H. Scharonow, M. Gathmann, D. Mamerow, and T. Werfel, "Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis," The Journal of Allergy and Clinical Immunology, vol. 126, no. 6, pp. 1176.e1-1183.e1, 2010.
24. H. Y. Tan, A. L. Zhang, D. Chen, C. C. Xue, and G. B. Lenon, "Chinese herbal medicine for atopic dermatitis: a systematic review," Journal of the American Academy of Dermatology, vol. 69, no. 2, pp. 295-304, 2013.
25. H.-H. Kim, J.-S. Yoo, T.-Y. Shin, and S.-H. Kim, "Aqueous extract of Mosla chinensis inhibits mast cell-mediated allergic inflammation," The American Journal of Chinese Medicine, vol. 40, no. 6, pp. 1257-1270, 2012.
26. K.-L. E. Hon, T.-F. Leung, Y. Wong et al., "A pentaherbs capsule as a treatment option for atopic dermatitis in children: an openlabeled case series," The American Journal of Chinese Medicine, vol. 32, no. 6, pp. 941-950, 2004.
27. K. L. Hon, B. C. Chan, and P. C. Leung, "Chinese herbal medicine research in eczema treatment," Chinese Medicine, vol. 6, article 17, 2011.
28. H.-M. Cheng, L.-C. Chiang, Y.-M. Jan, G.-W. Chen, and T.-C. Li, "The efficacy and safety of a Chinese herbal product (Xiao- Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial," International Archives of Allergy and Immunology, vol. 155, no. 2, pp. 141-148, 2011.
29. E. Cho and S. H. Cho, "Effects of Korean red ginseng extract on the prevention of atopic dermatitis and its mechanism on early lesions in a murine model," Journal of Ethnopharmacology, vol. 145, no. 1, pp. 294-302, 2013.
30. J. S. Hwang, J.-E. Kim, H.-T. Kim, Y.-B. Yu, and S.-H. Im, "Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis," Journal of Ethnopharmacology, vol. 145, no. 2, pp. 536-546, 2013.
31. D.-Y. Kim, J.-A. Jung, T.-H. Kim, S.-W. Seo, S.-K. Jung, and C.-S. Park, "Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitislike skin lesions via IFN-gamma down-regulation in NC/Nga mice," Journal of Ethnopharmacology, vol. 122, no. 3, pp. 567-572, 2009.
32. Q.-F. Xie, J.-H. Xie, T. T. X. Dong et al., "Effect of a derived herbal recipe froman ancient Chinese formula, Danggui Buxue Tang, on ovariectomized rats," Journal of Ethnopharmacology, vol. 144, no. 3, pp. 567-575, 2012.
33. A. J. Frew, "Allergen immunotherapy," The Journal of Allergy and Clinical Immunology, vol. 125, supplement 2, pp. S306-S313, 2010.
34. M. E. Rothenberg and S. P. Hogan, "The eosinophil," Annual Review of Immunology, vol. 24, pp. 147-174, 2006.
35. J. H. Kim, M. H. Kim, G. Yang, Y. Huh, S.-H. Kim, and W. M. Yang, "Effects of topical application of Astragalus membranaceus on allergic dermatitis," Immunopharmacology and Immunotoxicology, vol. 35, no. 1, pp. 151-156, 2013.